affected in pain states [2] [3] [4] [5] . More specifically, it has been found that pressure pain thresholds (PPTs) are lower in the tibialis anterior muscle in patients with chronic low back pain compared to controls [2] . Furthermore, research has reported an association between long-lasting low back pain and localized as well as generalized lower PPTs [3, 4] . Yet, no association has been found between recently developed low-back pain and PPTs [3] . Thus, it appears that deep-tissue hypersensitivity exists in individuals with long-lasting but not short-term low back pain [3] . Lower local and general PPTs, both in frequent episodic tension-type headache and chronic tension-type headache, compared to healthy controls has been found in earlier research [5] . However, evidence for lowering of only local PPTs, not general PPTs has been found in other studies examining chronic tension type headache [6, 7] . With regard to pain sensitivity in acute pain, PPTs in acute musculoskeletal pain showed localized hyperalgesia but not generalized hyperalgesia [8] .
Furthermore, it is not clear if general PPTs are affected in all pain states regardless of pain persistence. Studying generalized hypersensitivity with regard to pain persistence is important, since there is some evidence that generalized hypersensitivity is not present in acute or subacute pain stages [9] , but the knowledge about exactly when generalized hypersensitivity develops during a painful experience is lacking. It is also unclear if the pain must be persistent, or if generalized hypersensitivity also develops during long-lasting regularly recurrent pain. In addition, no connection to pain intensity has been considered in previous research.
The aim of the present study was to investigate pressure pain thresholds in a pain-free body area in patients with musculoskeletal pain, and specifically whether such thresholds depend on the persistence, duration, and intensity of pain. It was hypothesized that patients with persistent, long-lasting pain, but not patients with acute or long-lasting regularly recurrent pain, would show substantial generalized deep tissue hypersensitivity. In order to determine the existence of generalized deep tissue hypersensitivity among these pain groups, we used a group of healthy controls as a benchmark. It was further hypothesized that higher perceived pain intensity would predict lower PPTs.
Material and methods

Study population
Patients seeking a physiotherapist at a primary health care facility in southern Sweden for pain in the musculoskeletal system were recruited. Inclusion criteria: musculoskeletal pain and fluency in Swedish. Exclusion criteria: diagnosed cognitive impairment, psychiatric diagnoses except depression as a secondary diagnosis, brain damage, being under 18 years of age, and pain in the L4 dermatome or L5 dermatome region of the lower right leg. The same participants were also asked to participate in a study of cognitive function. Patients (5%) who declined to participate did so due to lack of time or because they did not want to participate in research projects. The current sample consisted of 214 participants (72 males, 129 females), aged 18−80 years. Thirteen patients were excluded due to drug or alcohol abuse or to psychiatric diseases not known to the physiotherapist at the first meeting. This was done when the patient records at the primary health care center were searched for exclusion criteria. Every patient record was searched for exclusion criteria after the first meeting and the patient was asked about exclusion criteria at the first meeting. All participants signed an informed consent form and the study was approved by the regional ethics review board in Linköping (2012/173-31).
All patients were diagnosed according to ICD-10, (Table 1) . If the patient fitted into more than one diagnose category, they were placed in the category which resembled the problem for which they were seeking the physiotherapist treatment. Patients were asked whether they experienced pain in more than one body region and the number of affected body parts were noted ( Table 2) . Patients were divided into three groups according to oral description of their pain history in terms of the pain duration and pain persistence. Patients with acute pain (pain for less than 3 months) were placed in one group, patients with regularly recurrent pain (discrete episodic, regularly recurrent pain, with pain-free periods between, for at least several times a week and at least for 3 months) in another group and patients with persistent pain (persistent pain for at least 3 months) in a third group. The control group consisted of staff at the primary health care center, people accompanying patients to the primary health care center, employees from a private company in the southern part of Sweden, and of former patients who had recovered from acute pain.
Patients were asked for information about current medication. Medications in the group with acute pain consisted of paracetamol, NSAID and opioids. Medications in the group with regularly recurrent pain consisted of paracetamol, NSAID and opioids. Medications in the group with persistent pain consisted of paracetamol, NSAID, opioids, antidepressant drugs, anti-epileptics, sleeping drugs, muscular relaxants and folic acid analogues. Pain-relieving medication in the acute pain group was used temporarily, in the regularly recurrent pain group sporadically since these patients did not have constant pain signaling. In the persistent pain group, the painrelieving medications were used continually, since these patients experienced constant pain signaling.
Instruments
A Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (the worst imaginable pain) was used to measure pain intensity [10] . A manual Somedic algometer (Somedic AB, Sweden) with a tip size area of 1 cm 2 was used to measure PPTs. All PPTs were assessed with an application rate of 30 kPa/s.
Protocol
Two different experienced physiotherapists diagnosed, treated and tested the patients. Both physiotherapists had earlier experience of measuring PPTs with a manual algometer. All patients were examined and diagnosed before the PPT measurement. During the PPT measurement patients were asked to lie down on an examiner's bench with no clothing on the lower part of the right leg. When in supine position, the participant was asked to estimate his/her pain intensity on VAS. After this, three consecutive PPT measurements were conducted over the middle part of the right tibialis anterior muscle belly. The patients held a signal button connected to the Somedic algometer in their dominant hand and pressed the button when the perceived pressure turned into a painful sensation. When the button was pressed, the PPT measurement was interrupted. If no painful sensation had been induced by 1500 kPa pressure, the measurement was interrupted and this was considered as a missing value. A mean value of the three PPTs was calculated and later used in statistical analyses.
Results
We first analyzed whether the PPTs were normally distributed. This was not the case and thus the PPTs were log-transformed. After transformation of data, the variable followed a normal distribution, allowing us to use parametric tests in our subsequent analyses. Also, the PPTs met the assumption of homogeneity of variance among the different pain groups. Descriptive statistics and (untransformed) PPTs for the healthy control, acute pain, regularly recurrent pain, and the persistent pain groups appear in Table 2 and Fig. 1, respectively. 
PPTs
In order to test our first hypothesis that patients with persistent, long-lasting pain, but not patients with acute or long-lasting regularly recurrent pain, would show substantial generalized deep tissue hypersensitivity, we performed three planned comparisons where each pain group was compared to healthy controls. Because the gender distribution across the four pain groups was uneven and because we found that gender was significantly related to PPTs in our sample, t (202) = 6.04, p < 0.001, we included gender as M545  M544  M542  M754  M797  M17  M16  G448  Other   Acute pain  16  5  6  7  1  3  Regularly recurrent pain  12  7  16  11  5  5  Persistent pain  13  7  8  6  9  4  1  2  2   Table 2 Baseline characteristics of study population presented in sub-groups. Mean and standard deviations in all groups of age, VAS score and pain duration. Gender distribution in all groups. Frequency of pain in more than one body region in all groups and frequency of intake of pain reliving medication in all groups at the test session. a covariate when conducting our main analyses. Additional analyses showed that pain-relieving medication (p = 0.216) and age (p = 0.786) were not significantly associated with the PPTs. Thus, these variables did not qualify as covariates in the main analyses. As expected, the first planned comparison showed that the persistent pain group had significantly lower PPTs compared to healthy controls, F (1, 100) = 9.70, p = 0.01, Cohen's d = 0.72. Achieved power to detect a moderate effect size (equivalent to Cohen's d = 0.5) given the current group sizes (n = 52 vs. n = 51) was 0.83 with alpha set at 0.05, one-tailed. In contrast, the second planned comparison revealed that the acute pain group did not differ significantly from the healthy control group, F (1, 86) = 0.23, p = 0.63, Cohen's d = 0.17. Achieved power to detect a moderate effect size (equivalent to Cohen's d = 0.5) given the current group sizes (n = 38 vs. n = 51) was 0.75 with alpha set at 0.05, one-tailed. Finally, the third planned comparison showed that the regularly recurrent pain group did not differ significantly from the healthy control group, F (1, 104) = 1.04, p = 0.31, Cohen's d = 0.07. Achieved power to detect a moderate effect size (equivalent to Cohen's d = 0.5) given the current group sizes (n = 56 vs. n = 51) was 0.82 with alpha set at 0.05, one-tailed. Taken together, the results support our first hypothesis.
Pain intensity and PPTs
Performing a correlational analysis between VAS scores and PPTs for the three groups that reported pain (acute pain, regularly recurrent pain, and the persistent pain groups), a significant correlation emerged, r s = -0.25, p < 0.01. Thus, consistent with our second hypothesis, higher reported pain intensity was associated with lower PPTs, although this relationship was weak.
Discussion
It was hypothesized that patients with persistent, long-lasting pain, but not patients with acute or long-lasting regularly recurrent pain, would show substantial generalized deep tissue hypersensitivity. Indeed, we found that the group with persistent pain had substantially (Cohen's d = 0.72) lower PPTs compared to healthy controls, but that the acute and regularly recurrent pain groups did not differ significantly from this control group. This finding is consistent with the idea that a general deep hypersensitivity develops among patients with persistent, long-lasting pain but not yet in patients with acute or long-lasting regularly recurrent pain. However, because our study had sufficient power (according to conventional standards) to only detect effect sizes that are moderate in magnitude (e.g. Cohen's d = 0.5), our study may have failed to detect generalized deep tissue hypersensitivity in the acute and regularly recurrent pain groups that corresponds to a small effect size according to conventional standards. Thus, it is possible that some generalized deep tissue hypersensitivity exists in these groups. Larger studies that are statistically powered to detect small effects are thus needed to resolve this issue. Yet, what can be more confidently concluded from our study is that generalized deep tissue hypersensitivity appears to be more pronounced among patients with persistent pain as compared to patients with acute or regularly recurrent pain, and if generalized deep tissue hypersensitivity occurs in the latter groups, it is likely to be relatively minor.
For patients with acute pain, this is in accordance with an earlier study examining both localized and generalized PPTs after acute inversion ankle sprains, where generalized PPTs were not affected [8] . Another study, examining PPTs in individuals experiencing frequent episodic tension-type headache found that this group showed significantly lower PPTs (over tibialis anterior muscle) compared to healthy controls [5] . This is inconsistent with the results from our study, where patients with regularly recurrent pain did not show lower PPTs compared to healthy controls in a pain-free body part. Perhaps, these discrepant results are due to the specified diagnose of tension-type headache in the headache study compared to the heterogeneous musculoskeletal pain sample in our study, even if both studies examined long-lasting frequently regularly recurring pain. It is interesting to note that it was discovered in a study that the same musculoskeletal diagnosis (unilateral shoulder pain) yielded a great deal of individual differences in patterns of localized and generalized hypersensitivity [11] . In that study, not all patients developed a generalized hypersensitivity. It has also been proposed that inconsistent findings could be due to heterogeneity in sampling. It appears that subtypes of different chronic pain states and pain conditions are complex and often inadequately described in studies [12] . The musculoskeletal pain states in a primary care setting are very heterogeneous, which complicate the sampling procedure, and therefore large standard deviations were a complication in our sample. To improve this in future studies within primary care, one could restrict the patient sample to certain diagnoses. On the other hand, in reality, the complexity in different pain states means that even within the same diagnose, the pain sample is heterogeneous, since every pain experience is unique [13] . Sample age could also differ between different studies. Samples with working age participants are commonly used (18−65 years), but since persons over 65 years of age also experience acute pain, regularly recurrent pain and persistent pain, and painful conditions are common in older patients, we did not exclude elderly persons.
For those patients in our study, who were in some kind of pain state (i.e. acute, regularly recurrent, and persistent pain groups), a significant correlation emerged between clinical pain (VAS-score) and PPTs. Thus, higher perceived pain intensity was associated with lower PPTs, although this relationship was weak with only 6% explained variance. This is consistent with our second hypothesis.
Different pain-relieving medications were used in our sample and there were continuous intake in about half the persistent pain group. Most patients in the persistent pain group received a mix of different pain-relieving drugs. These drugs could influence sensitization in persistent pain, for example, pregabalin and gabapentin reduce the sensitization elicited in the dorsal horn and in peripheral nociceptors [14] . According to this, the PPTs in the persistent pain group, were these medications existed could without these drugs have been even lower. When it comes to opioids as a pain-relieving medication, opioid-induced hyperalgesia has been described in literature [15] , were spinal cord hyper-excitability has been suggested. Possibly, this could lower peripheral PPTs in patients with long-term use of opioids. Anti-depressant drugs are used in painrelief to decrease central sensitization through increase of certain neurotransmitters (5-HT, noradrenalin) in the spinal cord [16] . In the persistent pain group, where antidepressant drugs were used for pain relief, the PPTs could possibly have been even lower without anti-depressant medication. However, in the present sample no effect of pain-relieving medication on PPTs was found statistically.
There are some limitations to our study. For example, participants with depression as a secondary diagnosis were not excluded, nor were the degree of depression or anxiety measured and controlled for statistically. It has been shown in one earlier study that depression is associated with a reduced pain threshold [17] .
Furthermore, we did not control for any potential differences in sleep deprivation between the groups. One previous study on sleep deprivation has shown an association between sleep deprivation and decreased pain thresholds [17] . However, another study has shown no effect on thermal, cold, or pressure pain thresholds when individuals were deprived of sleep [18] .
Some previous studies have shown that women have lower pain thresholds than men, both in general [19, 20] , and when considering local pain areas and pain-free body parts [4] . This was also the case in our study. However, even when gender was controlled for statistically, we found that the persistent pain group had more pronounced pain hypersensitivity relative to the other groups.
Yet, what can be more confidently concluded from our study is that generalized deep tissue hypersensitivity is substantial for patients with long-lasting persistent pain but not for patients with acute or long-lasting regularly recurrent pain, and if generalized deep tissue hypersensitivity occurs in the latter groups, it is likely to be relatively minor. To the best of our knowledge, the current research was the first to examine generalized hypersensitivity in qualitatively different musculoskeletal disorders in a primary care setting. As a practical implication of the results, it could be argued that to prevent the development of general hypersensitivity, early pain-relief in acute and regularly recurrent pain states is of importance.
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